Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China Ocumension Therapeutics Feb 01, 2023 10:00 HKT/SGT Read More
Eisai: Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Accepted by European Medicines Agency Eisai Jan 27, 2023 10:46 HKT/SGT Read More
エーザイとバイオジェン、抗アミロイドβプロトフィブリル抗体「レカネマブ」について早期アルツハイマー病に係る販売承認申請が欧州医薬品庁により受理 Eisai Jan 27, 2023 08:30 JST Read More
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating Prenetics Global Limited Jan 26, 2023 12:16 HKT/SGT Read More
Eisai Commences Business Activities at New Pharma Sales Subsidiary in Israel Eisai Jan 19, 2023 09:35 HKT/SGT Read More
Eisai Listed as a Global 100 Most Sustainable Corporation for The Seventh Time Highest Ranked Global Pharmaceutical Company Eisai Jan 19, 2023 08:07 HKT/SGT Read More
Eisai Aims to Advance Gastrointestinal Cancer Treatment with Research Across Multiple Tumor Types at ASCO GI 2023 Eisai Jan 18, 2023 12:28 HKT/SGT Read More
Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer's Disease in Japan Eisai Jan 16, 2023 17:56 HKT/SGT Read More
エーザイ、抗アミロイドβプロトフィブリル抗体「レカネマブ」について、日本において早期アルツハイマー病に係る適応で新薬承認を申請 Eisai Jan 16, 2023 09:00 JST Read More
Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024 PCG Digital Jan 16, 2023 06:00 HKT/SGT Read More
NLS Pharmaceutics、同社の成長を続ける前臨床化合物ポートフォリオをレビューするR&Dアップデート ウェブキャストを開催 NLS Pharmaceutics Ltd. Jan 13, 2023 09:00 JST Read More
American Green (OTC:ERBB) Architectural Plans for Its 40,000 s.f. Cypress Chill Cannabis Grow are in the Final Review Phase American Green, Inc Jan 13, 2023 09:00 HKT/SGT Read More
Novotech 收購美國藥物開發諮詢公司 CBR International Novotech Health Holdings Pte Ltd Jan 12, 2023 15:00 HKT/SGT Read More